Feature Story: |
Teleflex, Becton Dickinson Lead US Central Venous Catheter Market Fueled by Antimicrobial Technology |
The average number of central venous catheters (CVC) kits used per successful CVC insertion is expected to decline in the next several years as the adoption of ultrasound guidance increases.
The largest CVC segment in 2017 was the acute CVC segment, which represented almost 90% of the total CVC market. The acute CVC market is a mature and stable market. While unit sales are declining, appreciating average selling prices (ASPs), due to the sales of more complex CVC kits, are driving...
Read more from this new research study
|
|
The total U.S. market for interventional cardiology devices was valued at $2.9 billion in 2017. Growth of the U.S. interventional cardiology market is highly correlated with annual procedural volume, particularly percutaneous coronary intervention (PCI) and angiography procedures. PCI procedural growth has a positive effect on the associated device markets, such as coronary stents, balloon catheters, interventional catheters and guidewires and various other devices required per procedure. Angiography procedure volumes are expected to... read more} |
|
|
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food and Drug Administration and U.S. commercial launch of new versions of its Expro Elite™ and Sympro Elite™ Snares for manipulating interventional devices in peripheral procedures.
Both the Expro Elite™ and Sympro Elite™ Snares represent next-generation versions of the 0.035” interventional snares originally launched in the U.S. in 2008 by Vascular Solutions, now a wholly-owned subsidiary of Teleflex Incorporated.
“We are excited to introduce... read more} |
|
Dextera Surgical Inc., a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that it had obtained approval by the Bankruptcy Court for the sale of substantially all of Dextera Surgical’s assets to Aesculap, Inc., a B. Braun company. The transaction is expected to be completed by February 20, 2018.
“We are pleased to see our innovative MicroCutter 5/80 Stapler, PAS-Port® and C-Port® automated anastomosis system cardiac surgery products and technology portfolio transitioning into... read more} |
|
Boston Scientific announced it agreed to buy a stake in Millipede Inc., which has developed a transcatheter-based treatment for severe mitral regurgitation, with the option of purchasing the entire company.
According to a press release from Boston Scientific, the company will purchase outstanding shares of Millipede along with newly issued shares of the privately held company for $90 million, with the option to acquire the remaining shares prior to the completion of a first-in-human clinical study of the severe mitral regurgitation treatment (Iris Transcatheter Annuloplasty Ring System).
When the study is completed, Millipede has the option to... read more} |
|
BD (Becton, Dickinson and Company), a leading global medical technology company, recently announced it has established a Product Security Partnership Program that emphasizes collaboration across the health care industry to enhance cybersecurity of medical technology and devices.
The new program has three primary components:
1. Participation with government agencies, industry associations and security researchers and their efforts to enhance cybersecurity in health care;
2. Collaborating with UL to use the ANSI UL 2900 cybersecurity standard and participate in the UL Cybersecurity Cooperative Research and Development Agreement; and... read more} |
|